Global Market Study on Bioinformatics - Asia to Witness Fastest Growth by 2020


  • Published On : Oct-2014 |
  • Pages : 88 Pages |
  • Format :

Bioinformatics is the combination of biology and information technology. It is used widely in the management of biological information in the field of medical, research and developments of drugs. It uses computer software tools for database creation, data management, data warehousing, data mining and communication networking. Bioinformatics deals with the recording, annotation, storage, analysis and retrieval of nucleic acid sequence, protein sequence and structural information. It has several applications in the fields of medicine and biology including molecular medicines, preventive medicines, gene therapy, drug developments, biotechnology and forensic analysis of microbes. It is also used in the study of genetics and genomes. Various advantages of bioinformatics include convenient and accurate verification of biological data, and storage and access to large amount of data. It also helps in fast sequence search through algorithm.

Owing to the growing applications of bioinformatics in drug discovery and development process, rising number of personalized medicines and clinical diagnostics also promotes use of bioinformatics. Moreover, growing information technology applications in bioinformatics and bioinformatics support in development of biomarker for safer drugs are some major drivers of the global bioinformatics market. Growth in information technology has resulted in various software innovations such as BLAST, Annotator, and GeneMark. These innovations are used in managing large amount of biological data in various research fields. In addition rising need for integrated bioinformatics system also boosted the growth of bioinformatics market. However, lack of skilled professionals and high costs for implementation of bioinformatics software are restraining the growth of the bioinformatics market. In addition, lack of interoperability among data formats is also restraining the growth of bioinformatics market.

Increasing number of merger and acquisition and new product innovation are some of the latest trend in bioinformatics market. Nanopore sequencing technology is one of the growth opportunities for the bioinformatics market

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). North America is dominating the global bioinformatics market due to growing applications of bioinformatics in drug discovery and development, growing information technology applications in bioinformatics and rising number of R&D activities. Asia is the fastest growing market for bioinformatics due to rising number of R&D activities and rising government fund for research and developments.

This report provides in-depth analysis and estimation of the global bioinformatics market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The bioinformatics market is categorized on the basis of sector, application and tools and services. Based on sector the bioinformatics market comprises medical biotechnology, gene therapy, academics, animal biotechnology, agriculture biotechnology, environmental biotechnology and forensic biotechnology. Medical biotechnology is dominating the global bioinformatics market. Based on tools and services, the market comprises bioinformatics content/knowledge management tools, bioinformatics platform and bioinformatics services.

Bioinformatics is the combination of biology and information technology. It is used widely in the management of biological information in the field of medical research and development of drugs. It uses computer software tools for database creation, data management, data warehousing, data mining and communication networking. Bioinformatics deals with the recording, annotation, storage, analysis and retrieval of nucleic acid sequence, protein sequence and structural information. It has several applications in the fields of medicine and biology including molecular medicines, preventive medicines, gene therapy, drug developments, biotechnology and forensic analysis of microbes. It is also used in the study of genetics and genomes. There are various bioinformatics tools available in the market categorized as homology and similarity tools, protein functional and analysis tools, sequence analysis tools and miscellaneous tools. As a result, the market is expected to grow at a CAGR of about 20.4% from 2014 to 2020.

Some of the major drivers which help in increasing demand for bioinformatics are growing applications of bioinformatics in drug discovery and development and increasing bioinformatics support in development of personalized medicines and clinical diagnostics. Rising need for integrated bioinformatics systems in proteomics and genomics also supports the growth of bioinformatics market. However, lack of skilled and trained professional and high cost is restraining the growth of the bioinformatics market. In addition, lack of interoperability among data formats is also restraining the growth of the bioinformatics market.

North America is the largest market for the global bioinformatics. Medical biotechnology is the largest market by sector and is expected to grow at a CAGR of about 21.6% from 2014 to 2020. Genomics is the largest application based bioinformatics market. In terms of growth, Asia is the fastest growing region due to rising government initiatives for research and development and improving IT infrastructure. Some of the fastest growing markets in Asia region are Japan, China and India.

Life Technologies is one of the leading players in the bioinformatics market. Other major players of bioinformatics market include Affymetrix, Inc., Bio-Rad Laboratories. and Agilent Technologies. 

Some of the major companies operating in the global bioinformatics market :

  • Life Technologies
  • Illumina, Inc.
  • Agilent Technologies and Active Motif, Inc.
  • Bio-Rad Laboratories QIAGEN
  • Knome, Inc.
  • GE Healthcare
  • Quest Diagnostics 
  • Others

These market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.

Chapter 1 Preface 

1.1 Report description

1.2 Research methodology 

1.3 Assumptions

Chapter 2 Market synopsis 

Chapter 3 Porter’s five forces analysis 

3.1 Bargaining power of suppliers

3.2 Bargaining power of buyers

3.3 Threat of new entrants 

3.4 Threat of substitutes 

3.5 Intensity of rivalry 

Chapter 4 Industry overview 

4.1 Market definition

4.2 Market drivers 

      4.2.1 Growing applications of bioinformatics in drug discovery and development

      4.2.2 Growing information technology applications in bioinformatics 

      4.2.3 Increasing bioinformatics support in development of personalized medicines and clinical diagnostics 

      4.2.4 Bioinformatics support development of biomarkers for safer drugs 

      4.2.5 Rising need for integrated bioinformatics systems in proteomics and genomics 

4.3 Impact analysis of market drivers 

4.4 Market restraints 

      4.4.1 High cost and lack of skilled professionals

      4.4.2 Lack of interoperability among data formats

4.5 Impact analysis of market restraints 

4.6 Market trends

      4.6.1 Increasing number of mergers and acquisitions 

      4.6.2 Rising number of product innovations 

4.7 Market opportunities 

      4.7.1 Nanopore sequencing technology 

Chapter 5 Global market size and forecast 

Chapter 6 Market size and forecast by sector 

6.1 Medical biotechnology 

6.2 Gene therapy 

6.3 Academics 

6.4 Animal biotechnology 

6.5 Agriculture biotechnology 

6.6 Environmental biotechnology 

6.7 Forensic biotechnology 

Chapter 7 Market size and forecast by application

7.1 Genomics 

7.2 Chemoinformatics and drug design

7.3 Proteomics 

7.4 Transcriptomics 

7.5 Metabolomics 

7.6 Molecular phylogenomics

Chapter 8 Market size and forecast by tools and services 

8.1 Bioinformatics content / knowledge management tools

8.2 Bioinformatics platforms 

8.3 Bioinformatics services 

Chapter 9 Market size and forecast by geography

9.1 North America 

9.2 Europe 

9.3 Asia 

Chapter 10 Competitive scenario

10.1 Market share 

10.2 Competitive benchmarking 

Chapter 11 Company profiles 

11.1 Active Motif, Inc. 

      11.1.1 Company overview 

      11.1.2 Products & services 

      11.1.3 Financial performance 

      11.1.4 Recent developments

11.2 Illumina, Inc. 

      11.2.1 Company overview 

      11.2.2 Products & services 

      11.2.3 Financial performance 

      11.2.4 Recent developments 

11.3 Life Technologies 

      11.3.1 Company overview 

      11.3.2 Products & services 

      11.3.3 Financial performance 

      11.3.4 Recent developments 

11.4 Affymetrix, Inc.

      11.4.1 Company overview

      11.4.2 Products & services 

      11.4.3 Financial performance 

      11.4.4 Recent developments 

11.5 Agilent Technologies

      11.5.1 Company overview

      11.5.2 Products & services 

      11.5.3 Financial performance 

      11.5.4 Recent developments 

11.6 Bio-Rad Laboratories 

      11.6.1 Company overview 

      11.6.2 Products & services 

      11.6.3 Financial performance 

      11.6.4 Recent developments

11.7 QIAGEN 

      11.7.1 Company overview 

      11.7.2 Products & services 

      11.7.3 Financial performance 

      11.7.4 Recent developments 

11.8 Knome, Inc. 

      11.8.1 Company overview 

      11.8.2 Products & services 

      11.8.3 Financial performance 

      11.8.4 Recent developments 

11.9 GE Healthcare 

      11.9.1 Company overview 

      11.9.2 Products & Services 

      11.9.3 Financial Performance 

      11.9.4 Recent Developments 

11.10 Geneva Bioinformatics SA 

      11.10.1 Company overview 

      11.10.2 Products & services

      11.10.3 Financial performance

      11.10.4 Recent Developments 

11.11 Quest Diagnostics 

      11.11.1 Company overview 

      11.11.2 Products & services

      11.11.3 Financial performance

      11.11.4 Recent Developments


List of Tables

TABLE 1 Market snapshot: Global market of bioinformatics (2014 and 2020) 

TABLE 2 R&D investment in pharmaceutical industry, by major countries (USD Million) in 2010 and 2011

TABLE 3 Drivers for bioinformatics market: impact analysis 

TABLE 4 Restraints for bioinformatics market: impact analysis 

TABLE 5 Some major mergers and acquisitions in bioinformatics market

TABLE 6 Some products launched by various companies 

TABLE 7 Global bioinformatics market size, by region, 2010 – 2013 (USD million)

TABLE 8 Global bioinformatics market size, by region, 2014 – 2020 (USD million) 

TABLE 9 Global bioinformatics market size, by sector, 2010 – 2013 (USD million) 

TABLE 10 Global bioinformatics market size, by sector, 2014 – 2020 (USD million) 

TABLE 11 Global bioinformatics market size, by application, 2010 – 2013 (USD million)

TABLE 12 Global bioinformatics market size, by application, 2014 – 2020 (USD million)

TABLE 13 Global bioinformatics market size, by tools and services, 2010 – 2013 (USD million) 

TABLE 14 Global bioinformatics market size, by tools and services, 2014 – 2020 (USD million)

TABLE 15 Medical biotechnology market size, by region, 2010 – 2013 (USD million)

TABLE 16 Medical biotechnology market size, by region, 2014 – 2020 (USD million) 

TABLE 17 Gene therapy market size, by region, 2010 – 2013 (USD million) 

TABLE 18 Gene therapy market size, by region, 2014 – 2020 (USD million) 

TABLE 19 Academics market size, by region, 2010 – 2013 (USD million)

TABLE 20 Academics market size, by region, 2014 – 2020 (USD million) 

TABLE 21 Animal biotechnology market size, by region, 2010 – 2013 (USD million) 

TABLE 22 Animal biotechnology market size, by region, 2014 – 2020 (USD million) 

TABLE 23 Agriculture biotechnology market size, by region, 2010 – 2013 (USD million) 

TABLE 24 Agriculture biotechnology market size, by region, 2014 – 2020 (USD million) 

TABLE 25 Environmental biotechnology market size, by region, 2010 – 2013 (USD million) 

TABLE 26 Environmental biotechnology market size, by region, 2014 – 2020 (USD million) 

TABLE 27 Forensic biotechnology market size, by region, 2010 – 2013 (USD million) 

TABLE 28 Forensic biotechnology market size, by region, 2014 – 2020 (USD million)

TABLE 29 Genomics market size, by region, 2010 – 2013 (USD million) 

TABLE 30 Genomics market size, by region, 2014 – 2020 (USD million)

TABLE 31 Chemoinformatics and drug design market size, by region, 2010 – 2013 (USD million)

TABLE 32 Chemoinformatics and drug design market size, by region, 2014 – 2020 (USD million)

TABLE 33 Proteomics market size, by region, 2010 – 2013 (USD million) 

TABLE 34 Proteomics market size, by region, 2014 – 2020 (USD million) 

TABLE 35 Transcriptomics market size, by region, 2010 – 2013 (USD million) 

TABLE 36 Transcriptomics market size, by region, 2014 – 2020 (USD million) 

TABLE 37 Metabolomics market size, by region, 2010 – 2013 (USD million) 

TABLE 38 Metabolomics market size, by region, 2014 – 2020 (USD million) 

TABLE 39 Molecular phylogenomics market size, by region, 2010 – 2013 (USD million)

TABLE 40 Molecular phylogenomics market size, by region, 2014 – 2020 (USD million) 

TABLE 41 Bioinformatics content/knowledge management tools market size, by region, 2010 – 2013 (USD million) 

TABLE 42 Bioinformatics content/knowledge management tools market size, by region, 2014 – 2020 (USD million)

TABLE 43 Bioinformatics platform market size, by region, 2010 – 2013 (USD million) 

TABLE 44 Bioinformatics platform market size, by region, 2014 – 2020 (USD million) 

TABLE 45 Bioinformatics services market size, by region, 2010 – 2013 (USD million) 

TABLE 46 Bioinformatics services market size, by region, 2014 – 2020 (USD million) 

TABLE 47 The North American bioinformatics market size, by region, 2010 – 2013 (USD million) 

TABLE 48 The North American bioinformatics market size, by region, 2014 – 2020 (USD million)

TABLE 49 The European bioinformatics market size, by region, 2010 – 2013 (USD million) 

TABLE 50 The European bioinformatics market size, by region, 2014 – 2020 (USD million) 

TABLE 51 The Asia bioinformatics market size, by region, 2010 – 2013 (USD million) 

TABLE 52 The Asia bioinformatics market size, by region, 2014 – 2020 (USD million)

TABLE 53 Active Motif, Inc.’s major product and service categories 

TABLE 54 Illumina, Inc.’s major product and service categories

TABLE 55 Life Technologies major product and service categories 

TABLE 56 Affymetrix, Inc.’s major product and service categories

TABLE 57 Agilent Technologies’s major product and service categories

TABLE 58 Bio-Rad Laboratories major product and service categories 

TABLE 59 Qiagen’s major product and service categories 

TABLE 60 Q Knome, Inc.’s major product and service categories 

TABLE 61 GE Healthcare’s product and services categories 

TABLE 62 Geneva Bioinformatics SA’s major product and service categories 

TABLE 63 Quest Diagnostics major product and service categories 


List of Figures 

FIG. 1 Bioinformatics market: Porter’s five force analysis

FIG. 2 Applications of bioinformatics 

FIG. 3 Segments of bioinformatics 

FIG. 4 Global bioinformatics market, by region, 2013 (% share)

FIG. 5 Global bioinformatics market, by sector, 2013 (% share)

FIG. 6 Global bioinformatics market, by applications, 2013 (% share)

FIG. 7 Global bioinformatics market, by tools and services, 2013 (% share)

FIG. 8 Medical biotechnology market, by region, 2013 (% share) 

FIG. 9 Global gene therapy market, by region, 2013 (% share) 

FIG. 10 Global academics market, by region, 2013 (% share) 

FIG. 11 Global animal biotechnology market, by region, 2013 (% share)

FIG. 12 Global agriculture biotechnology market, by region, 2013 (% share) 

FIG. 13 Global environmental biotechnology market, by region, 2013 (% share) 

FIG. 14 Global forensic biotechnology market, by region, 2013 (% share) 

FIG. 15 Genomics market, by region, 2013 (% share) 

FIG. 16 Chemoinformatics and drug design market, by region, 2013 (% share)

FIG. 17 Proteomics market, by region, 2013 (% share) 

FIG. 18 Transcriptomics market, by region, 2013 (% share) 

FIG. 19 Metabolomics market, by region, 2013 (% share)

FIG. 20 Molecular phylogenomics market, by region, 2013 (% share)

FIG. 21 Bioinformatics content/knowledge management tools market, by region, 2013 (% share)

FIG. 22 Bioinformatics platform market, by region, 2013 (% share)

FIG. 23 Bioinformatics services market, by region, 2013 (% share) 

FIG. 24 The North American bioinformatics market, by region 2013 (% share) 

FIG. 25 The European bioinformatics market, by region, 2013 (% share) 

FIG. 26 The Asia bioinformatics market, by region, 2013 (% share) 

FIG. 27 Market share of bioinformatics software manufacturing companies 

FIG. 28 Competitive benchmarking of bioinformatics software manufacturing companies

FIG. 29 Illumina, Inc. revenue and net income, 2011 – 2013 (USD million) 

FIG. 30 Life Technologies revenue and net income, 2011 – 2013 (USD million) 

FIG. 31 Affymetrix, Inc. revenue and net income, 2011 – 2013 (USD million) 

FIG. 32 Agilent Technologies net revenue and net income, 2011 – 2013 (USD million) 

FIG. 33 Bio-Rad Laboratories net sales and net income, 2011 – 2013 (USD million) 

FIG. 34 Qiagen net sales and net income, 2011 – 2013 (USD million) 

FIG. 35 GE Healthcare revenue and profit 2011 – 2013 (USD million)

FIG. 36 Quest Diagnostics net revenue and net income, 2011 – 2013 (USD million)

Back To Top